Peer-reviewedCC BYCancers
High-Dose Intravenous Vitamin C and Mistletoe Therapy in Breast Cancer: A Prospective Cohort Study on Overall Survival in Palliative Care
4 affiliations
- 1Department of Family Medicine, Severance Hospital, Seoul 03722, Republic of Korea;
- 2Department of Family Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; (H.-E.R.); (B.P.)
- 3Department of Family Medicine, Yeom Chang Hwan Hospital, Seoul 05700, Republic of Korea;
- 4Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
Related
- Identification of palliative care needs and prognostic factors of survival for tailoring appropriate interventions in advanced oncological, renal, and pulmonary diseases: results from a prospective observational study in an Italian population.
- High-Dose Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury
- Safety and Recovery Profile of Propofol-Based Intravenous Sedation for Endoscopic Retrograde Cholangiopancreatography in Adults: A Prospective Single-Center Observational Study
- Vitamin D screening and targeted supplementation delays liver fibrosis in patients with chronic liver disease: A prospective randomized controlled trial
- Vitamin D status and lower urinary tract symptoms in children: Findings from a prospective comparative study
BibTeX
@article{lee2026highdose,
title = {{High-Dose Intravenous Vitamin C and Mistletoe Therapy in Breast Cancer: A Prospective Cohort Study on Overall Survival in Palliative Care}},
author = {Donghun Lee and Ha-Eun Ryu and Byoungjin Park and Chang Hwan Yeom and Seok-Jae Heo and Dong-Hyuk Jung},
journal = {Cancers},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664437},
note = {CC BY},
}
RIS
TY - JOUR
TI - High-Dose Intravenous Vitamin C and Mistletoe Therapy in Breast Cancer: A Prospective Cohort Study on Overall Survival in Palliative Care
AU - Donghun Lee
AU - Ha-Eun Ryu
AU - Byoungjin Park
AU - Chang Hwan Yeom
AU - Seok-Jae Heo
AU - Dong-Hyuk Jung
PY - 2026
DA - 2026/09/23
JO - Cancers
UR - https://europepmc.org/article/PMC/PMC13664437
SN - 2072-6694
ER -